AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014
Feb 20, 2014
30339_dirs_2014-02-20_6769bfdb-67a8-413d-b5d3-43bb1097ca3e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-02-18
Reporting Person: Hunt Jeffrey C (VP Pharma Pckg Systems)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-18 | Common Stock | A | 4345.0000 | $48.6900 | Acquired | 23992.0764 | Direct |
| 2014-02-18 | Common Stock | A | 6065.0000 | $48.6900 | Acquired | 21256.0232 | Indirect |
| 2014-02-18 | Common Stock | A | 4697.0000 | $48.6900 | Acquired | 25953.0232 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 653.2848 | Indirect |
Footnotes
F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2011 that have vested for performance period 10.
F2: Bonus and incentive shares granted on 2/18/2014.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12